FIELD: medicine.
SUBSTANCE: compounds have the property of a GPR119 receptor agonist and can be used as an active ingredient for pharmaceutical compositions in the form of tablets, capsules, injections, ointments, rectal suspensions and gels presented in a pharmaceutically acceptable pack, in treating metabolic diseases such as metabolic syndrome, diabetes mellitus, and obesity. In the general formula 
R=H, (C1-C5)alkyl, halogen-substituted (C1-C5)alkyl, acyl specified in a group of C1-C5alkylC(=O)- or phenyl(C=O)-, substituted heteroaryl representing an aromatic monocyclic group with two nitrogen atoms, which is substituted by a halogen atom or C1-C5alkyl, (C1-C3)alkylsulphonyl, phenylsulphonyl; R1, R2, R3, R4 represents hydrogen or one or two substitutes simultaneously specified in a halogen, (C1-C3)alkyl, halogen-substituted (C1-C3)alkyl, (C1-C3)alkylsulphonyl, a cyano group.
EFFECT: improving the properties.
8 cl, 1 dwg, 8 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOUNDS CONTAINING BENZO[D][1,3]OXATIOL, BENZO[D][1,3]OXATIOL-3-OXIDE OR BENZO[D][1,3]OXATIOL-3,3-DIOXIDE, AND METHODS/THEIR USE AS AGONISTS OF G-PROTEIN COUPLED RECEPTOR 119 | 2017 |
|
RU2794480C2 |
| SUBSTITUTED (R)-3-(4-METHYLCARBAMOYL-3-FLUOROPHENYLAMINO)-TETRAHYDRO-FURAN-3-ENE CARBOXYLIC ACIDS AND ESTERS THEREOF, METHOD FOR PRODUCTION AND USE THEREOF | 2013 |
|
RU2520134C1 |
| 1-OXO-3-(1H-INDOL-3-YL)-1,2,3,4-TETRAHYDROISOQUINOLINES, METHODS OF PREPARATION THEREOF, COMBINATORY LIBRARY, AND FOCUSED LIBRARY | 2006 |
|
RU2302417C1 |
| FURO- AND THIENO[2,3-b]-QUINOLINE-2-CARBOXAMIDES, METHOD OF PRODUCTION AND ANTITUBERCULOUS ACTIVITY | 2008 |
|
RU2371444C1 |
| SUBSTITUTED PYRAZINE PYRIMIDINONES AS TRPA1 CHANNEL BLOCKERS, PHARMACEUTICAL COMPOSITION, METHODS OF PRODUCTION AND USE THEREOF | 2014 |
|
RU2603770C2 |
| DERIVATIVES OF NOSCAPINE (VARIANTS), COMBINATORY AND FOCUSED LIBRARIES, PHARMACEUTICAL COMPOSITION, METHODS FOR THEIR PREPARING (VARIANTS) AND USING | 2006 |
|
RU2304584C1 |
| LIGANDS OF 5-HT RECEPTORS, PHARMACEUTICAL FORMULATION, PRODUCTION METHOD AND MEDICAL PRODUCT | 2006 |
|
RU2329044C1 |
| SUBSTITUTED 3,5-DIAMINO-4-SULFONYL-PYRAZOLES AND 2-AMINO-3-SULFONYL-PYRAZOLO-[1,5-a]PYRIMIDINES-ANTAGONISTS OF SEROTONIN 5-HT RECEPTORS, METHODS FOR THEIR PRODUCTION AND USE | 2008 |
|
RU2376291C1 |
| SUBSTITUTED [1,2,4]TRIAZOLO[4,3-a]PYRIDINES, DEMONSTRATING PROPERTIES OF ANTAGONISTS OF ADENOSINE A2A RECEPTORS, AND THEIR APPLICATION | 2013 |
|
RU2534804C1 |
| SUBSTITUTED 2-THIOXO-IMIDAZOLIDIN-4-ONE, AND SPIROANALOGUES THEREOF, ANTICANCER ACTIVE INGREDIENT, PHARMACEUTICAL COMPOSITION, MEDICINAL PRODUCT, METHOD OF TREATING PROSTATE CANCER | 2014 |
|
RU2557235C1 |
